Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma

Ophthalmic Research

Volumn 37, Issue 1, 2005, Pages 23-28

  Nareyeck, Gordon ^a   Zeschnigk, Michael ^a   Von Der Haar, Daniela ^a   Schilling, Harald ^a   Bornfeld, Norbert ^a   Anastassiou, Gerasimos ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chromosome 3; Gene expression analysis; Immunohistochemistry; Tissue inhibitor of matrix metalloproteinases 3; Uveal melanoma

Indexed keywords

MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CANCER CYTODIAGNOSIS; CELL TYPE; CHROMOSOME 3; CLINICAL FEATURE; CONTROLLED STUDY; DISOMY; GENETIC ANALYSIS; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MONOSOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEIN SYNTHESIS; STAINING; TISSUE SECTION; UVEA MELANOMA;

CHROMOSOMES, HUMAN, PAIR 3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MELANOMA; MONOSOMY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UVEAL NEOPLASMS;

EID: 18644375749     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082940     Document Type: Article

References (16)

1. Gamel JW, McLean IW, McCurdy JB: Biologic distinctions between cure and time to death in 2,892 patients with intraocular melanoma. Cancer 1993;71:2299-2305.
2. Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R: Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-1225.
3. Scholes AG, Damato BE, Nunn J, Hiscott P, Grierson I, Field JK: Monosomy 3 in uveal melanoma: Correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44:1008-1011.
4. Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC: Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997;19:22-28.
5. Tschentscher F, Husing J, Holter T, Kruse E, Dresen IG, Jockel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M: Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 2003;63:2578-2584.
6. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr: TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000;275:31226- 31232.
7. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA: Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 2003;106:472-479.
8. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, Zetter B, Apte SS: A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 1996;74:853-862.
9. Mannello F, Gazzanelli G: Tissue inhibitors of metalloproteinases and programmed cell death: Conundrums, controversies and potential implications. Apoptosis 2001;6:479-482.
10. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B: A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): Inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003;9:407-415.
11. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF: Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001;10:243-248.
12. Ahonen M, Poukkula M, Baker AH, Kashiwagi M, Nagase H, Eriksson JE, Kahari VM: Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene 2003;22:2121-2134.
13. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender's classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-509.
14. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM: The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-1398.
15. Kivela T: Immunohistochemical staining followed by bleaching of melanin: A practical method for ophthalmic pathology. Br J Biomed Sci 1995;52:325-326.
16. Fariss RN, Apte SS, Olsen BR, Iwata K, Milam AH: Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol 1997;150:323-328.